ADGM news

Latest 3 stories · newest Nov 5, 2026

ADGM

Adagio Medical Closing Reverse Stock Split

Adagio Medical Holdings Inc. filed documents to effect a 30-for-1 reverse stock split effective as of Nov. 6, 2026. This structural change to the company's capitalization will be a material development for shareholders.

Restructuring Nov 5, 2026 sentiment -0.20 SEC filing ↗

ADGM

Adagio Launches Strategic Review Process

Board to explore strategic alternatives to maximize shareholder value while advancing vCLAS PMA application and FULCRUM-VT trial. Cash reserves are approximately $7.7 million.

M&A Sep 23, 2026 sentiment 0.00 SEC filing ↗

ADGM

Adagio Medical submits PMA application to FDA for vCLAS VT ablation system

Adagio Medical announced FDA premarket approval submission for its vCLAS Ventricular Ablation System, supported by FULCRUM-VT pivotal trial data showing 97.4% acute success and 84.3% freedom from ICD. This marks the first PMA submission for a purpose-built VT ablation system in a $5.8B market, addre…

Regulatory May 21, 2026 sentiment +0.85 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same ADGM feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/ADGM/newsSTART FREE